| |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to governmental health benefit plan coverage for opioid |
|
|
antagonists and associated devices. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. Subtitle E, Title 8, Insurance Code, is amended |
|
|
by adding Chapter 1372 to read as follows: |
|
|
CHAPTER 1372. COVERAGE FOR OPIOID ANTAGONISTS |
|
|
Sec. 1372.001. DEFINITION. In this chapter, "opioid |
|
|
antagonist" means any drug that binds to opioid receptors and |
|
|
blocks or otherwise inhibits the effects of opioids acting on those |
|
|
receptors. |
|
|
Sec. 1372.002. APPLICABILITY OF CHAPTER. Notwithstanding |
|
|
any other law, this chapter applies only to: |
|
|
(1) a basic coverage plan under Chapter 1551; |
|
|
(2) a basic plan under Chapter 1575; |
|
|
(3) a primary care coverage plan under Chapter 1579; |
|
|
(4) a plan providing basic coverage under Chapter |
|
|
1601; |
|
|
(5) the state Medicaid program, including the Medicaid |
|
|
managed care program operated under Chapter 533, Government Code; |
|
|
and |
|
|
(6) the child health plan program under Chapter 62, |
|
|
Health and Safety Code. |
|
|
Sec. 1372.003. REQUIRED COVERAGE FOR OPIOID ANTAGONISTS. A |
|
|
health benefit plan must provide coverage for an opioid antagonist |
|
|
and an associated device used in the administration of an opioid |
|
|
antagonist. |
|
|
SECTION 2. If before implementing any provision of this Act |
|
|
a state agency determines that a waiver or authorization from a |
|
|
federal agency is necessary for implementation of that provision, |
|
|
the agency affected by the provision shall request the waiver or |
|
|
authorization and may delay implementing that provision until the |
|
|
waiver or authorization is granted. |
|
|
SECTION 3. The change in law made by this Act applies only |
|
|
to a health benefit plan delivered, issued for delivery, or renewed |
|
|
on or after January 1, 2024. |
|
|
SECTION 4. This Act takes effect September 1, 2023. |